Fitch Ratings has assigned a grade of 2nd, out of a maximum of 5, to Aanjaneya Lifecare's (ALL) proposed initial public offering (IPO) of 5,000,000 equity shares, which indicates below-average fundamentals of the issue relative to other listed equity securities in India, according to its report dated February 23.
Company is a vertically integrated pharmaceutical company with manufacturing and marketing capabilities in APIs (active pharmaceutical ingredients) with focus on anti-malarial, and finished dosage forms (FDFs) catering to various therapeutic segments. The report says, "ALLDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
